HIF-1α signaling activation by post-ischemia treatment with astragaloside IV attenuates myocardial ischemia-reperfusion injury.
In this study, we evaluated the effect of astragaloside IV (Ast IV) post-ischemia treatment on myocardial ischemia-reperfusion (IR) injury (IRI). We also examined whether hypoxia inducible factor-1α (HIF-1α) and its downstream gene-inducible nitric oxide (NO) synthase (iNOS) play roles in the cardio...
Saved in:
| Main Authors: | Jingwen Si, Ning Wang, Huan Wang, Juan Xie, Jian Yang, Hui Yi, Zixuan Shi, Jing Ma, Wen Wang, Lifang Yang, Shiqiang Yu, Junchang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0107832 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ciprofol Ameliorates Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through Upregulating HIF-1α
by: Ding J, et al.
Published: (2024-12-01) -
Myocardial ischemia – reperfusion injury
by: S. V. Salo, et al.
Published: (2023-10-01) -
Xanthosine alleviates myocardial ischemia–reperfusion injury through attenuation of cardiomyocyte ferroptosis
by: Yang Xu, et al.
Published: (2025-07-01) -
Corrigendum to “Targeting HIF-1α to Prevent Renal Ischemia-Reperfusion Injury: Does It Work?”
by: Kapil Sethi, et al.
Published: (2019-01-01) -
IL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation
by: Yuzhen Wei, et al.
Published: (2023-06-01)